Search

Your search keyword '"A. Mejean"' showing total 3,107 results

Search Constraints

Start Over You searched for: Author "A. Mejean" Remove constraint Author: "A. Mejean"
3,107 results on '"A. Mejean"'

Search Results

1. Active Fluids: Effects of Hydrodynamic Stress on Growth of Self-Propelled Fluid Particles

3. TRUSTED: The Paired 3D Transabdominal Ultrasound and CT Human Data for Kidney Segmentation and Registration Research

4. Is “Kidney Stone Calculator” efficient in predicting ureteroscopic lithotripsy duration? A holmium:YAG and thulium fiber lasers comparative analysis

5. Open versus robotic partial nephrectomy in obese patients: a multi-institutional propensity score-matched analysis (UroCCR 43—Robese study)

8. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

10. UroPredict: Machine learning model on real-world data for prediction of kidney cancer recurrence (UroCCR-120)

12. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

14. Predicting odor profile of food from its chemical composition: Towards an approach based on artificial intelligence and flavorists expertise

15. Late complications and 5 years outcomes of robotic partial nephrectomy in France: prospective assessment in the French Kidney Cancer Research Network (UroCCR 10)

27. An Exploratory Study on Visual Exploration of Model Simulations by Multiple Types of Experts

28. Application of Machine Learning Models to Predict Recurrence After Surgical Resection of Nonmetastatic Renal Cell Carcinoma

30. Subclinical rejection-free diagnostic after kidney transplantation using blood gene expression

34. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

35. SAT-016 Assessment of the role of liver transplantation with or without combined kidney transplantation in polycystic liver or liver and kidney disease

36. Slowdown of the surface diffusion during early stages of bacterial colonization

42. Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial

50. Improving Business-as-Usual Scenarios in Land Change Modelling by Extending the Calibration Period and Integrating Demographic Data

Catalog

Books, media, physical & digital resources